Telix Pharmaceuticals Limited Other Comprehensive Income Net Of Tax Exchange Differences On Translation
Telix Pharmaceuticals Limited (TLPPF) reported Other Comprehensive Income Net Of Tax Exchange Differences On Translation of -$5.76 million for the 12-month period ending 2025-12-31, per its 20-F filed 2026-02-20.
Financial Statements › Income Statement › Unrealized Gains
ifrs-full:OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation · last filed 2026-02-20
AUD
| Period end | Other Comprehensive Income Net Of Tax Exchange Differences On Translation 12 month |
|---|---|
| 2024-12-31 | 47.68M AUD 20-F · filed 2025-02-24 |
| 2023-12-31 | -4.85M AUD 20-F · filed 2025-02-24 |
| 2022-12-31 | 591.00K AUD 20-F · filed 2025-02-24 |
USD
| Period end | Other Comprehensive Income Net Of Tax Exchange Differences On Translation 12 month |
|---|---|
| 2025-12-31 | -$5.76M 20-F · filed 2026-02-20 |
| 2024-12-31 | $5.57M 20-F · filed 2026-02-20 |
| 2023-12-31 | -$1.86M 20-F · filed 2026-02-20 |